4//SEC Filing
Shoemaker Stephen H 4
Accession 0001213900-25-056270
CIK 0001690080other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:45 PM ET
Size
7.9 KB
Accession
0001213900-25-056270
Insider Transaction Report
Form 4
Shoemaker Stephen H
Director
Transactions
- Award
Common Stock
2025-06-17+72,297→ 137,297 total - Award
Non-Qualified Stock Option (right to buy)
2025-06-17+165,000→ 165,000 totalExercise: $0.93Exp: 2035-06-17→ Common Stock (165,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan.
- [F2]Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer.
- [F3]The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0002048098
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:45 PM ET
- Size
- 7.9 KB